Close Menu

Trovagene

NEW YORK (GenomeWeb News) – Trovagene today said it has completed its acquisition of the CLIA laboratory of MultiGen Diagnostics.

TrovaGene said this week that it has obtained an exclusive worldwide license for mutations of the SF3B1 splicing factor that are associated with disease progression and chemotherapy response in chronic lymphocytic leukemia.

PrimeraDx this week announced that it has appointed Leroy Hood to its scientific advisory board.

NEW YORK (GenomeWeb News) – TrovaGene today said that it has licensed exclusive worldwide rights to assay technology for the detection of hairy cell leukemia.

By Monica Heger
This story, originally published Aug. 11, has been updated to include comments from TrovaGene co-founder Gabriele Cerrone.

Canon, Philipps-Universität Marburg, Johns Hopkins University, Brandeis University, Samsung, City of Hope, Amplion, and Trovagene are awarded US patents.

US patents awarded to LLNL, TrovaGene, Rockefeller U, Gen-Probe, Human Genetic Signatures, Riken, DNAForm, U of Utah, Idaho Tech, Rubicon, Cepheid, Toshiba, Chang Gung University, Samsung, Apodemus, and Robert-Koch Institut.

Pages

The Wall Street Journal reports that Russia's announcement of a coronavirus vaccine approval was met with concern as safety testing has not yet been completed.

New Scientist writes there aren't much data available on the accuracy of the two rapid COVID-19 tests the UK plans to roll out.

In PNAS this week: downstream effect of oncoprotein fusion, epigenetic changes influence tRNAs in colon cancer, and more.

Nature News reports that recent proposed changes to the US National Science Foundation have raised concerns about a shift away from the agency's focus on basic research.